Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce H Morimoto

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|September 28, 2017
Therapeutic peptides for CNS indications: Progress and challengesBruce H Morimoto
Handbook of Experimental Pharmacology|June 21, 2015
Safety Pharmacology in Drug Discovery and DevelopmentBruce H Morimoto, Erin Castelloe, Anthony W Fox
Journal of Pharmacological and Toxicological Methods|June 8, 2019
Translatability of the S7A core battery respiratory safety pharmacology studies: Preclinical respiratory and related clinical adverse eventsSabina Paglialunga, Bruce H Morimoto, Matthew Clark, et al.
Expert Opinion on Investigational Drugs|August 10, 2007
Looking for novel ways to treat the hallmarks of Alzheimer's diseaseAlistair J Stewart, Anthony Fox, Bruce H Morimoto, et al.
Drug, Healthcare and Patient Safety|May 2, 2018
Evaluating cardiac risk: exposure response analysis in early clinical drug developmentJulie Grenier, Sabina Paglialunga, Bruce H Morimoto, et al.
Therapeutic Delivery|July 28, 2012
Drug development of intranasally delivered peptidesCatherine Campbell, Bruce H Morimoto, Daniela Nenciu, et al.
Clinical Pharmacology in Drug Development|February 15, 2018
Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes SubjectsSabina Paglialunga, Bruce H Morimoto, Amparo de la Peña, et al.
Expert Review of Clinical Pharmacology|August 27, 2013
Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseasesBruce H Morimoto, Anthony W Fox, Alistair J Stewart, et al.
Expert Review of Clinical Pharmacology|December 22, 2016
Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelinesSabina Paglialunga, Elliot Offman, Nita Ichhpurani, et al.
Dementia and Geriatric Cognitive Disorders|April 19, 2013
A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairmentBruce H Morimoto, Don Schmechel, Joe Hirman, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|September 28, 2017
Therapeutic peptides for CNS indications: Progress and challengesBruce H Morimoto
Handbook of Experimental Pharmacology|June 21, 2015
Safety Pharmacology in Drug Discovery and DevelopmentBruce H Morimoto, Erin Castelloe, Anthony W Fox
Journal of Pharmacological and Toxicological Methods|June 8, 2019
Translatability of the S7A core battery respiratory safety pharmacology studies: Preclinical respiratory and related clinical adverse eventsSabina Paglialunga, Bruce H Morimoto, Matthew Clark, et al.
Expert Opinion on Investigational Drugs|August 10, 2007
Looking for novel ways to treat the hallmarks of Alzheimer's diseaseAlistair J Stewart, Anthony Fox, Bruce H Morimoto, et al.
Drug, Healthcare and Patient Safety|May 2, 2018
Evaluating cardiac risk: exposure response analysis in early clinical drug developmentJulie Grenier, Sabina Paglialunga, Bruce H Morimoto, et al.
Therapeutic Delivery|July 28, 2012
Drug development of intranasally delivered peptidesCatherine Campbell, Bruce H Morimoto, Daniela Nenciu, et al.
Clinical Pharmacology in Drug Development|February 15, 2018
Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes SubjectsSabina Paglialunga, Bruce H Morimoto, Amparo de la Peña, et al.
Expert Review of Clinical Pharmacology|August 27, 2013
Davunetide: a review of safety and efficacy data with a focus on neurodegenerative diseasesBruce H Morimoto, Anthony W Fox, Alistair J Stewart, et al.
Expert Review of Clinical Pharmacology|December 22, 2016
Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelinesSabina Paglialunga, Elliot Offman, Nita Ichhpurani, et al.
Dementia and Geriatric Cognitive Disorders|April 19, 2013
A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairmentBruce H Morimoto, Don Schmechel, Joe Hirman, et al.
Pageof 2